Charles Schwab
KYMR icon

Charles Schwab’s Kymera Therapeutics KYMR Stock Holding History

Charles Schwab’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.3M Sell
495,262
-1,764
-0.4% -$140K 0.01% 1278
2025
Q4 		$38.7M Buy
497,026
+57,201
+13% +$3.86M 0.01% 1319
2025
Q3 		$24.9M Buy
439,825
+10,521
+2% +$475K ﹤0.01% 1612
2025
Q2 		$18.7M Buy
429,304
+47,596
+12% +$1.64M ﹤0.01% 1711
2025
Q1 		$10.4M Sell
381,708
-5,479
-1% -$200K ﹤0.01% 1932
2024
Q4 		$15.6M Buy
387,187
+20,346
+6% +$919K ﹤0.01% 1822
2024
Q3 		$17.4M Sell
366,841
-8,260
-2% -$365K ﹤0.01% 1773
2024
Q2 		$11.2M Buy
375,101
+20,995
+6% +$727K ﹤0.01% 1992
2024
Q1 		$14.2M Buy
354,106
+47,414
+15% +$1.7M ﹤0.01% 1810
2023
Q4 		$7.81M Buy
306,692
+4,951
+2% +$88.5K ﹤0.01% 2121
2023
Q3 		$4.19M Buy
301,741
+639
+0.2% +$12.8K ﹤0.01% 2334
2023
Q2 		$6.92M Buy
301,102
+2,605
+0.9% +$74.6K ﹤0.01% 2082
2023
Q1 		$8.84M Buy
298,497
+589
+0.2% +$19K ﹤0.01% 1930
2022
Q4 		$7.44M Buy
297,908
+19,348
+7% +$516K ﹤0.01% 2009
2022
Q3 		$6.07M Buy
278,560
+22,018
+9% +$580K ﹤0.01% 2117
2022
Q2 		$5.05M Buy
256,542
+1,265
+0.5% +$29.5K ﹤0.01% 2182
2022
Q1 		$10.8M Buy
255,277
+6,743
+3% +$285K ﹤0.01% 1915
2021
Q4 		$15.8M Buy
248,534
+5,309
+2% +$309K ﹤0.01% 1752
2021
Q3 		$14.3M Buy
243,225
+139,149
+134% +$8.07M ﹤0.01% 1811
2021
Q2 		$5.05M Buy
104,076
+41,628
+67% +$1.81M ﹤0.01% 2353
2021
Q1 		$2.43M Buy
62,448
+1,114
+2% +$67.1K ﹤0.01% 2608
2020
Q4 		$3.8M Buy
+61,334
New +$2.99M ﹤0.01% 2350

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return